Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 171 participants.

Also called NCT04870047

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 171 participants (enrolled count) (from the registry)
Sponsor
  • Phenox GmbH Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04870047
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France, Germany, Israel, Italy, Slovakia, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04870047. Randomized; no masking; primary purpose treatment. Start 2021-09-03 (actual); primary completion 2024-12-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation
Acronym
COATING
Condition
Intracranial Aneurysm
Intervention (Device)
Endovascular treatment of unruptured aneurysms with p64 MW HPC Flow Modulation Device
Lead sponsor
Phenox GmbH (class: industry)

Record details

Record id
cardio:ct-nct04870047
Content hash
86ecf17c84435eab0c5499b3cabd80b50419f3ea6a72c65a00844b1b6d89546e